Is There an Antibody for Prostate Cancer?

Is There an Antibody for Prostate Cancer?

In the study published in the journal Oncotarget, 10 men with metastatic prostate cancer resistant to androgen deprivation therapy and the androgen receptor antagonist enzalutamide were treated with pembrolizumab, a monoclonal antibody that binds to the PD-1 receptor.

Read More

New Drugs Target Prostate Cancer

New Drugs Target Prostate Cancer

Men with aggressive prostate cancer that has stopped responding to conventional treatment could benefit from a new class of cancer drug designed to overcome drug resistance, a new study suggests.

Read More